|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/522 | (2006.01) |
| A61K 31/4985 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 9/04 | (2006.01) |
| (11) | Number of the document | 2015754 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07728723.3 |
| Date of filing the European patent application | 2007-05-03 | |
| (97) | Date of publication of the European application | 2009-01-21 |
| (45) | Date of publication and mention of the grant of the patent | 2014-04-09 |
| (46) | Date of publication of the claims translation | 2014-07-25 |
| (86) | Number | PCT/EP2007/054270 |
| Date | 2007-05-03 |
| (87) | Number | WO 2007/128761 |
| Date | 2007-11-15 |
| (30) | Number | Date | Country code |
| 06009203 | 2006-05-04 | EP |
| (72) |
DUGI, Klaus, DE
HIMMELSBACH, Frank, DE
MARK, Michael, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | DPP-IV inhibitorių panaudojimas |
| USES OF DPP-IV INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2016-04-21 | 10 | 231.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2017-03-31 |